REGENERON PHARMACEUTICALS, INC.
SEC Filing List
REGN CIK: 0000872589
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 13F-HR | Initial Quarterly Form 13F Holdings Repo... | Toppan Merrill/FA | 05/08/2026 | ||
| 4 | Statement of changes in beneficial owner... | Ryan Arthur F | Regeneron Pharmaceuticals, Inc. | 05/04/2026 | |
| SCHEDULE 13G | 04/30/2026 | ||||
| 10-Q | Quarterly report pursuant to Section 13 ... | Regeneron Pharmaceuticals, Inc. | 04/29/2026 | ||
| 8-K | Current report filing | Regeneron Pharmaceuticals, Inc. | 04/29/2026 | ||
| DEF 14A | Definitive proxy statements | Regeneron Pharmaceuticals, Inc. | LABRADOR CO /fa | 04/24/2026 | |
| ARS | Annual report to security holders | Regeneron Pharmaceuticals, Inc. | Toppan Merrill/FA | 04/24/2026 | |
| DEFA14A | Definitive additional proxy soliciting m... | Regeneron Pharmaceuticals, Inc. | LABRADOR CO /fa | 04/24/2026 | |
| 8-K | Current report filing | Regeneron Pharmaceuticals, Inc. | Toppan Merrill/FA | 04/08/2026 | |
| 4 | Statement of changes in beneficial owner... | Ryan Arthur F | Toppan Merrill/FA | 04/03/2026 | |
| No record found. | |||||
| Load More | |||||
